Belmont, CA, United States of America

Charles M Winter

USPTO Granted Patents = 7 

 

 

Average Co-Inventor Count = 1.5

ph-index = 3

Forward Citations = 49(Granted Patents)


Location History:

  • York, PA (US) (1988)
  • Belmont, CA (US) (2012 - 2023)

Company Filing History:

goldMedal6 out of 3,221 
 
Genentech, Inc.
 patents
silverMedal3 out of 3,923 
 
Novartis Ag
 patents
bronzeMedal1 out of 832,718 
Other
 patents
where one patent can have more than one assignee

Years Active: 1988-2025

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovations of Charles M Winter

Introduction

Charles M Winter is a notable inventor based in Belmont, CA, with a remarkable portfolio of seven patents. His work primarily focuses on the concentration of antibodies and therapeutic products, contributing significantly to advancements in biotechnology.

Latest Patents

One of his latest patents is titled "Process for concentration of antibodies and therapeutic products thereof." This patent outlines a process for concentrating proteins through a sequence of ultrafiltering and diafiltering at elevated temperatures, specifically above 30° C. The disclosure also includes methods for preparing highly concentrated antibody compositions and products, showcasing his innovative approach to protein concentration.

Career Highlights

Throughout his career, Charles has worked with prominent companies in the biotechnology sector, including Genentech, Inc. and Novartis AG. His contributions to these organizations have been instrumental in developing new therapeutic solutions.

Collaborations

Charles has collaborated with notable professionals in his field, including Arthur Huang and Robert F Kelley. These partnerships have further enhanced his research and development efforts.

Conclusion

Charles M Winter's contributions to the field of biotechnology through his innovative patents and collaborations highlight his significant impact on the industry. His work continues to pave the way for advancements in therapeutic products and antibody concentration methods.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…